CNR2 and prostate carcinoma: CBD induced anti-proliferative effects and apoptosis-mediated cell death (via the intrinsic pathway) in prostate cancer cells, which may be dependent on CB2, but not CB1, and the transient receptor potential cation channel subfamily M member 8 (TRPM8) receptor in LNCaP cells [112,113].